Home Capital Broker's Calls

Raffles Medical Group gets an upgrade as long-term growth stays on track

Samantha Chiew
Samantha Chiew9/21/2017 11:48 AM GMT+08  • 2 min read
Raffles Medical Group gets an upgrade as long-term growth stays on track
SINGAPORE (Sept 21): UOB Kay Hian is upgrading its call on Raffles Medical Group (RMG) to “buy” from “hold” with a target price of $1.28.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Sept 21): UOB Kay Hian is upgrading its call on Raffles Medical Group (RMG) to “buy” from “hold” with a target price of $1.28.

To recap, since UOB Kay Hian downgraded the group to “hold” in April, its shares have declined about 22%.

In a Thursday report, analyst Andrew Chow says, “While earnings outlook for the next two years will likely be crimped by start-up losses in China, we believe growth over the next 10 years will be significantly enhanced where capacity will more than quadruple.”

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.